1. "2017"
  2. "Elsevier Inc."
  3. "Genitourinary Oncology Service"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
Groups
  1. Department of Medicine (14)
  2. Genitourinary Oncology Service (14)
  3. Solid Tumor Oncology Division (14)
  4. Population Sciences Research Program (4)
  5. Surgery (4)
  6. Urology (4)

More Groups

People
  1. Robert Motzer (6)
  2. Darren Feldman (3)
  3. James Hsieh (3)
  4. Maria Carlo (3)
  5. Abraham Hakimi (2)
  6. Brandon Manley (2)

More People

Years
  1. 2017 (14)
Publications
  1. European Journal of Cancer (4)
  2. Clinical Genitourinary Cancer (2)
  3. Urologic Oncology: Seminars and Original Investigations (2)
  4. Biology of Blood and Marrow Transplantation (1)
  5. Experimental Cell Research (1)
  6. International Journal of Radiation Oncology, Biology, Physics (1)

More Publications

Publishers
  1. Elsevier Inc. (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) is not predictive of outcomes in germ CE cancer patients receiving autologous transplantation
    Meeting Abstract

    Greenberg, D.; Shah, G. L.; Maloy, M.; Devlin, S. M.; Giralt, S. A.; Perales, M. A.; Feldman, D. R.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Does neoadjuvant androgen deprivation therapy impact erectile function recovery post-radical prostatectomy?
    Meeting Abstract

    Jenkins, L.; Touijer, K.; Rathkopf, D.; Nelson, C.; Mulhall, J.
    Journal of Sexual Medicine (2017)

    Fulltext@MSK | Save
  • PD-L1 tumor expression and its effect on overall survival among patients with resected non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Sui, J.; Teo, M. Y.; Rafee, S.; Mc Fadden, J.; Gately, K.; Barr, M.; Gray, S.; Cuffe, S.; Finn, S.
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study
    Meeting Abstract

    Grande, E.; Choueiri, T. K.; Motzer, R. J.; Escudier, B.; Pal, S.; Kollmannsberger, C.; Pikiel, J.; Gurney, H.; Rha, S. Y.; Park, S. H.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study
    Meeting Abstract

    Necchi, A.; Bellmunt, J.; De Wit, R.; Vaughn, D.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N.; Climent, M.; Petrylak, D.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR)
    Meeting Abstract

    Schmidinger, M.; Motzer, R. J.; Powles, T.; Escudier, B.; Tannir, N. M.; Mainwaring, P. N.; Rini, B. I.; Hammers, H. J.; Donscov, F.; Roth, B.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: Results from the phase 3 METEOR study
    Meeting Abstract

    Bracarda, S.; Choueiri, T. K.; Powles, T.; Motzer, R. J.; Olencki, T.; Frontera, O. A.; Oudard, S.; Rolland, F.; Tomczak, P.; Castellano, D.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Genomic characterization of renal medullary carcinoma and treatment outcomes
    Journal Article

    Carlo, M. I.; Chaim, J.; Patil, S.; Kemel, Y.; Schram, A. M.; Woo, K.; Coskey, D.; Nanjangud, G. J.; Voss, M. H.; Feldman, D. R.; more...
    Clinical Genitourinary Cancer (2017)

    Fulltext@MSK | Save
  • Mapping the functional landscape of ERCC2 mutations in muscle-invasive bladder cancer
    Meeting Abstract

    Frazier, Z.; Damish, A.; Reznichenko, E.; Liu, D.; Rosenberg, J.; Van Allen, E.; Lazaro, J. B.; D'Andrea, A. D.; Mouw, K.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer
    Journal Article

    Hsieh, J. J.; Manley, B. J.; Khan, N.; Gao, J.; Carlo, M. I.; Cheng, E. H.
    Seminars in Cell and Developmental Biology (2017)

    Fulltext@MSK | Save